𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver resection for recurrent hilar cholangiocarcinoma

✍ Scribed by E. M. Targarona; G. Zografos; Mr. N. A. Habib


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
135 KB
Volume
80
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Transplantation for hilar cholangiocarci
✍ Julie K. Heimbach; Michael G. Haddock; Steven R. Alberts; Scott L. Nyberg; Micha πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

## Key Points 1. Patients with primary sclerosing cholangitis (PSC) have a 8 to 12% risk of developing cholangiocarcinoma (CCA). 2. Cytologic techniques for aneuploidy such as digital image analysis and fluorescence in situ hybridization increase the detection rate for CCA. 3. Survival following re

Patterns of initial disease recurrence a
✍ William R. Jarnagin; Leyo Ruo; Sarah A. Little; David Klimstra; Michael D'Angeli πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract ## BACKGROUND Current approaches to adjuvant treatment after resection of gallbladder carcinoma (GBCA) and hilar cholangiocarcinoma (HCCA) are based on an incomplete understanding of the recurrence patterns of these diseases. Through an in‐depth analysis of the sites of initial recurre

Vascular complications after orthotopic
✍ Hendrik T.J. Mantel; Charles B. Rosen; Julie K. Heimbach; Scott L. Nyberg; Micha πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB

Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node-negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC). However, concern has arisen regarding the pot